LF
ELV icon

Longbow Finance’s Elevance Health ELV Stock Holding History

Longbow Finance’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,962
Closed -$5.7M – 86
2024
Q3 		$5.7M Sell
10,962
-2,864
-21% -$1.53M 0.61% 46
2024
Q2 		$7.49M Sell
13,826
-765
-5% -$404K 0.77% 31
2024
Q1 		$7.57M Sell
14,591
-17,439
-54% -$8.67M 0.77% 34
2023
Q4 		$15.1M Buy
32,030
+1,470
+5% +$680K 1.53% 20
2023
Q3 		$13.3M Sell
30,560
-106
-0.3% -$48.1K 1.6% 21
2023
Q2 		$13.6M Sell
30,666
-20
-0.1% -$9.23K 1.59% 21
2023
Q1 		$14.1M Sell
30,686
-3,064
-9% -$1.46M 1.78% 18
2022
Q4 		$17.3M Buy
+33,750
New +$17.1M 2.33% 11

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Longbow Finance's ELV Position: Q4 2024 in Review

Longbow Finance sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 10,962 shares — an estimated $5.7M sold.

Longbow Finance first reported a position in ELV in Q4 2022 and held it in 8 quarters. The position peaked at $17.3M in Q4 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Longbow Finance reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Longbow Finance sold 10,962 Elevance Health shares in Q4 2024, an estimated $5.7M.
  • Longbow Finance first reported a position in Elevance Health in Q4 2022 and held it in 8 quarters.
  • Longbow Finance's Elevance Health position peaked at $17.3M in Q4 2022.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Longbow Finance's 13F filing for Q4 2024, filed 4 Feb 2025.